Whistleblower Suit Alleges McKesson Sold Cancer Drugs Illegally

The U.S. government and 30 states have sued McKesson Corp., alleging that one of the nation’s oldest and largest healthcare companies illegally pooled leftover cancer medication and then sold it to health-care providers in an effort to maximize profits.

The whistleblower lawsuit, filed last week in the U.S. District Court for the Eastern District of New York, alleges McKesson violated the False Claims Act. Specifically, the government contends the company extracted “overfill” from single-use vials of cancer drugs and then repackaged it into non-sterile plastic syringes. By doing so, the suit says, McKesson “knowingly and intentionally put cancer patients and others with compromised immune systems at serious risk for infection, and defrauded federal, state, and local governments out of hundreds of millions of dollars.”

Last year, the federal government accused AmerisourceBergen, one of McKesson’s main competitors, of similar actions.

Both cases started by whistleblowers who came forward to report the fraud.

If you or someone you know has information about corporate fraud involving pharmaceutical drugs, or fraud against federal, state or local government funding, you should contact a whistleblower lawyer at Ross Feller Casey immediately. Ross Feller Casey is among the nation’s top firms handling False Claims Act lawsuits. You may be entitled to a substantial recovery. Please contact Ross Feller Casey’s experienced whistleblower attorneys for a free, confidential case review.